Standing by Our Decision: How EXONDYS 51 Became Part of Our Treatment Plan
This content is sponsored by Sarepta Therapeutics and is intended for US audiences only. Any other present or future content posted by the contributors, not expressly designated as “Sarepta Therapeutics-sponsored content,” is not associated with Sarepta. Dave’s son Xavier is an actual patient who is taking EXONDYS 51 (eteplirsen).